Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)PRESSE MEDICALEIF3.42019-03-015PREAI
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting AntiviralsANNALS OF HEPATOLOGYIF4.42019-01-013OAAI
INTERFERON-FREE TREATMENT OF CHRONIC HEPATITIS C WITH DIRECT-ACTING ANTIVIRAL AGENTS: AGE IS NO LONGER AN UNFAVORABLE PROGNOSTIC FACTORJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
INTERFERON-FREE, DIRECT-ACTING ANTIVIRAL AGENTS REGIMENS IN HEPATITIS C ARE MORE EFFECTIVE, BETTER TOLERATED, AND DECREASE FATIGUE DURING TREATMENT IN REAL-LIFE CONDITIONSJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
SOFOSBUVIR AND DACLATASVIR COMBINED TREATMENT FOR CHRONIC HEPATITIS C: FIRST-YEAR EFFICACY AND SAFETY DATA IN A REAL-LIFE SETTINGJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
HUMAN ALBUMIN USE IN CIRRHOTIC PATIENTS IN FRANCE: RESULTS OF THE NATIONAL ALBU-LIVE SURVEYJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
NEW DIRECT ACTING ANTIVIRALS FOR HEPATITIS C TREATMENT: FIRST RESULTS IN A REAL-LIFE SETTING IN FRANCEJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
TREATMENT OF HEPATOCELLULAR CARCINOMA WITH SORAFENIB: RESULTS IN THE REAL LIFE OF CHANGH COHORTJOURNAL OF HEPATOLOGYIF332011-03-010OAAI
Coeliac disease in chronic hepatitis C: a French multicentre prospective studyALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72007-08-2415OAAI
A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundiceHEPATOLOGYIF15.82003-04-0134PREAI
DOES ELECTIVE SCLEROTHERAPY IMPROVE THE EFFICACY OF LONG-TERM PROPRANOLOL FOR PREVENTION OF RECURRENT BLEEDING IN PATIENTS WITH SEVERE CIRRHOSIS - A PROSPECTIVE MULTICENTER, RANDOMIZED TRIALHEPATOLOGYIF15.81992-10-0134OAAI
TREATMENT OF SEVERE ALCOHOLIC HEPATITIS BY INFUSION OF INSULIN AND GLUCAGON - A MULTICENTER SEQUENTIAL TRIALHEPATOLOGYIF15.81992-01-0156OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向